Resvent RXiBreeze PAP System

· Resvent Holding USA LTD

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Resvent RXiBreeze PAP System, covering 2024-12-02 to 2024-12-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Resvent RXiBreeze™ PAP System to Treat Obstructive Sleep Apnea [NA]